Modification of port-access coronary artery bypass in high-risk patients

D R Watson1, W D Watson

  • 1Department of Cardiothoracic Surgery, Riverside Methodist Hospitals, Columbus, Ohio, USA.

Insights

Axilloaxillary and femoral-descending aortic cannulation offer safe alternatives for cardiopulmonary bypass in patients with severe peripheral vascular disease, avoiding risks associated with traditional femoral sites.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Vascular Access

Background:

  • Minimally invasive port-access coronary artery bypass surgery offers advantages for patients with comorbidities.
  • Standard femoral artery and vein cannulation carry risks, particularly with arteriosclerotic or aneurysmal disease.

Purpose of the Study:

  • To evaluate axilloaxillary or femoral-descending aortic cannulation as alternative sites for cardiopulmonary bypass.
  • To mitigate risks of cerebral and systemic embolization associated with traditional cannulation sites.

Main Methods:

  • Utilized Heartport endovenous and endoaortic cannulas in 9 patients.
  • Performed axilloaxillary or femoral-descending aortic cardiopulmonary bypass.
  • Patients had severe peripheral vascular disease or abdominal aortic aneurysms.

Main Results:

  • Successful cardiopulmonary bypass achieved in all patients.
  • No complications related to arm neurovascular structures.
  • 100% 30-day survival with no neurological complications.
  • Axillary arteriotomies closed primarily without issue.

Conclusions:

  • Axilloaxillary and femoral-descending aortic cannulation are viable alternative sites for cardiopulmonary bypass.
  • These methods are suitable for patients with severe peripheral vascular disease.
  • Standard Heartport cannulas facilitate these alternative cannulation strategies.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...